“SECONDARY PROPHYLAXIS OF VENOUS THROMBOEMBOLISM (VTE) WITH LOW DOSE APIXABAN OR RIVAROXABAN: RESULTS FROM A PATIENT POPULATION WITH MORE THAN 2 YEARS OF MEDIAN FOLLOW-UP”. Mediterranean Journal of Hematology and Infectious Diseases 16, no. 1 (February 29, 2024): e2024020. Accessed June 3, 2026. https://www.mjhid.org/mjhid/article/view/5567.